# Risedronate Sodium

NDC: 65862-519
Generic name: Risedronate Sodium
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20151130

FDA application: ANDA200296

## Active ingredients

- RISEDRONATE SODIUM: 35 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-519"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-519
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89896dfe-f69d-4cb3-bb71-7a7c611071fa